CMC logo.png
Checkmate Capital Group and KAIST Venture Investment Holdings Announce Partnership & Selection as TIPS Operator
June 26, 2022 23:12 ET | Checkmate Capital
LOS ANGELES and SEOUL, South Korea, June 26, 2022 (GLOBE NEWSWIRE) -- A consortium formed by KAIST Venture Investment Holdings and Checkmate Capital Group has been selected as a program operator for...
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
February 22, 2022 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for...
China License Signing Ceremony
Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction
January 25, 2022 22:30 ET | NeuroSigma, Inc.
Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in ChinaInitial launch of Generation 1.0 device followed by Generation 1.5 device, to deploy in mainland...
NeuroSigma Announces Promotion of Dr. Colin Kealey to President
January 11, 2022 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...
Signing Ceremony
NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
December 08, 2021 05:00 ET | NeuroSigma, Inc.
Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KTSignificant investment in NeuroSigma’s digital health and neuro-electronics platform ...
Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
November 03, 2021 10:00 ET | Lynx Biosciences, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today announced the successful closing of its Series Seed Preferred Stock...
CMC logo.png
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
November 02, 2020 10:00 ET | Checkmate Capital
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing anti-infective biologics, is pleased to announce the completion of...
CMC logo.png
NeuroSigma Receives Bridge Financing from Checkmate Capital
September 21, 2020 11:00 ET | Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”),...
Checkmate Capital Invests in Community Eco Power
September 18, 2019 09:00 ET | Checkmate Capital
LOS ANGELES, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Checkmate Capital has completed an investment in Community Eco Power (CEP), a leader in the waste-to-energy industry headquartered in Asheville, North...
Q2Earth, through Affiliated Entity, Completes Acquisition of Leading Organics Composting Company in Austin, Texas
January 23, 2019 08:30 ET | Q2Earth, Inc
Palm Beach, FL, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) through an affiliated entity called Earth Property Holdings LLC (“Earth Property”) has...